- Home
- ICON vs KTTA Comparison
ICON vs KTTA Comparison
Compare ICON & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICON
- KTTA
- Stock Information
- Founded
- ICON 2023
- KTTA 2020
- Country
- ICON Greece
- KTTA United States
- Employees
- ICON N/A
- KTTA 4
- Industry
- ICON
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- ICON
- KTTA Health Care
- Exchange
- ICON Nasdaq
- KTTA Nasdaq
- Market Cap
- ICON 4.7M
- KTTA 5.5M
- IPO Year
- ICON 2024
- KTTA 2021
- Fundamental
- Price
- ICON $2.21
- KTTA $0.71
- Analyst Decision
- ICON Strong Buy
- KTTA
- Analyst Count
- ICON 1
- KTTA 0
- Target Price
- ICON $4.50
- KTTA N/A
- AVG Volume (30 Days)
- ICON 37.5K
- KTTA 201.4K
- Earning Date
- ICON 09-10-2025
- KTTA 11-12-2025
- Dividend Yield
- ICON 426.34%
- KTTA N/A
- EPS Growth
- ICON N/A
- KTTA N/A
- EPS
- ICON N/A
- KTTA N/A
- Revenue
- ICON $6,137,000.00
- KTTA N/A
- Revenue This Year
- ICON $94.05
- KTTA N/A
- Revenue Next Year
- ICON $18.81
- KTTA N/A
- P/E Ratio
- ICON N/A
- KTTA N/A
- Revenue Growth
- ICON 25.60
- KTTA N/A
- 52 Week Low
- ICON $1.60
- KTTA $0.65
- 52 Week High
- ICON $130.80
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- ICON 51.92
- KTTA 42.46
- Support Level
- ICON $1.87
- KTTA $0.74
- Resistance Level
- ICON $2.37
- KTTA $0.81
- Average True Range (ATR)
- ICON 0.11
- KTTA 0.06
- MACD
- ICON 0.04
- KTTA -0.01
- Stochastic Oscillator
- ICON 67.00
- KTTA 9.21
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).